Christian Bréchot has been the President of Institut Pasteur since October 1st, 2013. His research mainly focuses on viral hepatitis: hepatitis B (HBV) and C (HCV), particularly with regard to their role in liver cancer (Hepatocellular carcinoma: HCC) and to the molecular mechanisms that drive liver regeneration and cancer (in particular, cell cycle deregulation).  His research activities have led him to obtain 13 patents and to contribute to the creation of two biotech companies : Rarecells and ALFACT Innovation.
Read more.